YHR213W-B Antibody

What is YHR213W-B and why is it significant for research?

YHR213W-B is an uncharacterized protein in Saccharomyces cerevisiae (strain 204508/S288c), commonly known as Baker's yeast . As an uncharacterized protein, determining its function could potentially reveal novel cellular pathways relevant to fundamental biological processes. The protein is of particular interest to researchers studying yeast genetics, protein function, and evolutionary conservation of cellular mechanisms. Antibodies against this protein serve as critical tools for elucidating its expression patterns, subcellular localization, and potential interactions with other cellular components.

What types of YHR213W-B antibodies are available for research applications?

Based on available research resources, polyclonal antibodies against YHR213W-B are the most commonly utilized, with rabbit anti-Saccharomyces cerevisiae YHR213W-B antibodies being particularly well-documented . Polyclonal antibodies offer the advantage of recognizing multiple epitopes on the target protein, potentially increasing detection sensitivity in various experimental contexts. These antibodies can be used across multiple applications including Western blotting, immunohistochemistry, immunofluorescence, and immunoprecipitation, though optimization for each application is essential.

How can YHR213W-B antibody specificity be validated for research applications?

Validating antibody specificity is critical, especially for uncharacterized proteins like YHR213W-B. A multi-faceted validation approach should include:

Researchers should ideally combine multiple validation approaches to establish confidence in antibody specificity before proceeding with experimental applications.

What is the optimal protocol for Western blot analysis using YHR213W-B antibodies?

When optimizing Western blot protocols for YHR213W-B detection, researchers should consider:

• Sample preparation:

  • Harvest yeast cells in mid-log phase to ensure consistent protein expression

  • Use glass bead lysis or enzymatic methods with protease inhibitors to prevent degradation

  • Consider different extraction buffers based on protein solubility characteristics

• Electrophoresis and transfer:

  • Determine appropriate acrylamide percentage based on protein molecular weight

  • Optimize transfer conditions (wet vs. semi-dry, buffer composition, time, voltage)

• Antibody incubation:

  • Test antibody dilutions ranging from 1:500 to 1:5000

  • Compare overnight incubation at 4°C versus shorter incubations at room temperature

  • Evaluate different blocking agents (5% milk, 5% BSA, commercial blockers)

• Detection system:

  • Compare chemiluminescent, fluorescent, and colorimetric detection methods

  • Determine the linear range of detection for quantitative analysis

Since YHR213W-B is uncharacterized, it's advisable to run positive and negative controls alongside experimental samples for proper interpretation of results.

How can YHR213W-B antibodies be effectively used in immunoprecipitation experiments?

For successful immunoprecipitation of YHR213W-B from yeast lysates:

• Buffer optimization:

  • Test multiple lysis buffers varying in detergent type/concentration and salt content

  • For potentially weak interactions, consider mild buffers (e.g., 50 mM Tris pH 7.5, 100 mM NaCl, 0.1% NP-40)

  • For stronger validation, use more stringent conditions (e.g., 50 mM Tris pH 7.5, 300 mM NaCl, 1% Triton X-100)

• Antibody binding:

  • Determine optimal antibody amount (typically 2-5 μg per mg of protein lysate)

  • Compare direct antibody addition versus pre-binding to beads

  • Optimize incubation time (2 hours vs. overnight) and temperature

• Washing stringency:

  • Balance between removing non-specific interactions and preserving specific binding

  • Consider detergent concentration and salt concentration in wash buffers

  • Determine optimal number of washes (typically 3-5 washes)

• Elution and analysis:

  • Compare different elution methods (SDS sample buffer, acidic glycine, peptide competition)

  • Analyze by SDS-PAGE followed by Western blotting or mass spectrometry

This approach can be particularly valuable for identifying potential protein interaction partners of YHR213W-B.

How can flow cytometry be optimized for YHR213W-B detection in yeast cells?

Flow cytometry with yeast cells requires specialized sample preparation due to the cell wall. Drawing from methods used for other yeast proteins , the following protocol adaptations are recommended:

• Cell preparation:

  • Create spheroplasts using enzymatic digestion (zymolyase or lyticase)

  • Fix cells with 4% paraformaldehyde to preserve cellular architecture

  • Permeabilize with 0.1% Triton X-100 to allow antibody access

• Staining protocol:

  • Block with 3-5% BSA in PBS to reduce non-specific binding

  • Incubate with YHR213W-B primary antibody at optimized dilution (typically 1:100-1:500)

  • Use fluorophore-conjugated secondary antibody compatible with available cytometer lasers

• Critical controls:

  • Unstained cells for autofluorescence assessment

  • Secondary antibody only to determine background

  • YHR213W-B deletion strain as negative control

  • Known abundantly expressed yeast protein as positive staining control

• Analysis considerations:

  • Gate on single cells using forward and side scatter properties

  • Compare median fluorescence intensity between experimental and control samples

  • Consider cell cycle effects on protein expression levels

Similar approaches have been successfully applied for studying protein expression in K562 human cells , suggesting adaptability to various cell types including yeast.

What approach is recommended for studying YHR213W-B expression under different stress conditions?

A comprehensive experimental design for studying stress-induced changes in YHR213W-B expression should include:

• Stress condition selection:

  • Common yeast stressors: heat shock (37°C), oxidative stress (H₂O₂), osmotic stress (NaCl), nutrient deprivation

  • Test multiple stress intensities to identify threshold for response

  • Include time course sampling (15 min to 4+ hours) to capture dynamic responses

• Experimental controls:

  • Untreated controls for each time point

  • Known stress-responsive proteins as positive controls

  • Multiple biological replicates (minimum n=3)

• Analytical methods:

  • Western blotting with YHR213W-B antibody for protein levels

  • RT-qPCR for corresponding mRNA levels

  • Microscopy for potential changes in subcellular localization

• Data analysis:

  • Normalization to loading controls (e.g., PGK1, actin)

  • Statistical analysis across replicates

  • Correlation between protein and mRNA levels

This approach allows for comprehensive characterization of how YHR213W-B responds to various stress conditions, potentially providing insights into its biological function.

How can novel YHR213W-B protein interactions be identified and validated?

For identifying novel protein interactions of YHR213W-B, a multi-method approach is recommended:

• Co-immunoprecipitation with mass spectrometry:

  • Use YHR213W-B antibody to pull down protein complexes

  • Analyze by mass spectrometry to identify interacting partners

  • Compare against IgG control and YHR213W-B deletion samples

  • Establish statistical thresholds for significant interactions

• Proximity-based approaches:

  • Consider BioID or APEX2 fusion constructs with YHR213W-B

  • Identify proteins in close proximity in living cells

  • Compare with co-IP results to strengthen confidence

• Validation strategies:

  • Reciprocal co-IP with antibodies against potential interactors

  • Yeast two-hybrid assays for direct interaction testing

  • Bimolecular fluorescence complementation (BiFC) for in vivo validation

  • Co-localization studies using immunofluorescence

• Functional validation:

  • Phenotypic analysis of genetic interaction (e.g., synthetic lethality)

  • Biochemical assays to test functional relationship

  • Competitive binding assays to identify binding domains

This multi-layered approach helps distinguish genuine interactions from experimental artifacts and builds a network of potential YHR213W-B interactors.

What are common challenges when using YHR213W-B antibodies and how can they be resolved?

Researchers commonly encounter several challenges when working with antibodies against uncharacterized proteins like YHR213W-B:

Drawing from approaches used with other antibodies , systematic optimization of each experimental variable is essential for successful YHR213W-B detection.

How can epitope accessibility be improved for YHR213W-B antibody detection methods?

When working with potentially challenging proteins like YHR213W-B, epitope accessibility can significantly impact detection success:

• Sample preparation modifications:

  • Test multiple fixation methods (4% paraformaldehyde, methanol, or acetone)

  • Compare different permeabilization agents (Triton X-100, saponin, digitonin)

  • Evaluate antigen retrieval methods for fixed samples (heat-induced, enzymatic, pH-based)

• Antibody incubation optimization:

  • Test extended incubation times (overnight at 4°C)

  • Evaluate temperature effects (4°C vs. room temperature)

  • Consider additives to enhance penetration (0.1% Tween-20, 0.1% Triton X-100)

• Technical approaches:

  • For Western blotting: Test reducing vs. non-reducing conditions

  • For immunofluorescence: Compare pre-extraction protocols

  • For flow cytometry: Optimize permeabilization time and concentration

Similar epitope retrieval approaches have been successfully employed for other antibodies in human tissue samples , suggesting potential applicability to yeast proteins.

How can YHR213W-B antibodies be used in conjunction with CRISPR-Cas9 genome editing for functional studies?

Combining antibody-based detection with CRISPR-Cas9 genome editing offers powerful approaches for functional characterization:

• Knockout validation:

  • Generate CRISPR-mediated YHR213W-B knockout strains

  • Use antibody to confirm protein absence in knockout lines

  • Phenotypically characterize knockout strains to infer function

• Epitope tagging strategies:

  • Insert epitope tags via CRISPR-mediated homology-directed repair

  • Compare native protein detection (antibody) with tag detection

  • Use for validation of antibody specificity and function

• Domain mapping:

  • Create domain-specific deletions or mutations

  • Use antibody to assess effects on protein stability and localization

  • Correlate with functional phenotypes

• Regulatable expression:

  • Engineer CRISPR interference/activation systems for YHR213W-B

  • Monitor protein levels using antibody during repression/activation

  • Correlate expression changes with phenotypic outcomes

This integrated approach leverages both genomic manipulation and antibody-based detection for comprehensive functional analysis.

How can YHR213W-B antibodies be adapted for single-molecule studies?

For researchers interested in advancing to single-molecule resolution studies, several approaches can be considered:

• Super-resolution microscopy:

  • Use fluorophore-conjugated secondary antibodies compatible with STORM, PALM, or STED

  • Optimize sample preparation to minimize background fluorescence

  • Consider direct labeling of primary antibody to improve localization precision

• Single-molecule pull-down:

  • Immobilize YHR213W-B antibodies on functionalized surfaces

  • Capture individual protein complexes from dilute lysates

  • Combine with fluorescence detection for compositional analysis

• Proximity ligation assay (PLA):

  • Use YHR213W-B antibody in combination with antibodies against suspected interactors

  • Generate fluorescent signals only when proteins are in close proximity (<40 nm)

  • Quantify interaction events at single-molecule level

• Single-molecule tracking:

  • Label YHR213W-B antibody Fab fragments with photostable fluorophores

  • Track protein dynamics in minimally perturbed cells

  • Analyze diffusion characteristics to infer function and interactions

These approaches extend beyond conventional antibody applications to provide insights into protein behavior at the single-molecule level.